Literature DB >> 25677317

Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes.

John D Groarke1, Varsha K Tanguturi2, Jon Hainer3, Josh Klein3, Javid J Moslehi4, Andrea Ng5, Daniel E Forman6, Marcelo F Di Carli6, Anju Nohria7.   

Abstract

BACKGROUND: Hodgkin lymphoma (HL) survivors treated with thoracic radiation therapy (RT) have impaired exercise tolerance and increased cardiovascular mortality.
OBJECTIVES: The purpose of this study was to evaluate the prevalence of autonomic dysfunction and its implications on exercise capacity and mortality in long-term survivors of HL.
METHODS: Exercise parameters in 263 HL survivors referred for exercise treadmill testing at a median interval of 19 years after RT were compared with 526 age-, sex-, and cardiovascular risk score-matched control subjects. Within the RT cohort, the presence of autonomic dysfunction, defined by an elevated resting heart rate (HR) (≥80 beats/min) and abnormal heart rate recovery (HRR) at 1 min (≤12 beats/min if active cool-down, or ≤18 beats/min if passive recovery), was correlated with exercise capacity and all-cause mortality over a median follow-up of 3 years.
RESULTS: RT was associated with elevated resting HR and abnormal HRR after adjusting for age, sex, cardiovascular risk factors, medications, and indication for exercise treadmill testing: odds ratio: 3.96 (95% confidence interval [CI]: 2.52 to 6.23) and odds ratio: 5.32 (95% CI: 2.94 to 9.65), respectively. Prevalence of autonomic dysfunction increased with radiation dose and time from RT. Both elevated resting HR and abnormal HRR were associated with reduced exercise capacity in RT patients. Abnormal HRR was also associated with increased all-cause mortality (age-adjusted hazard ratio: 4.60 [95% CI: 1.62 to 13.02]).
CONCLUSIONS: Thoracic RT is associated with autonomic dysfunction, as measured by elevated resting HR and abnormal HRR. These abnormalities are associated with impaired exercise tolerance, and abnormal HRR predicts increased all-cause mortality in RT patients.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hodgkin lymphoma; abnormal heart rate recovery; cardiac autonomic dysfunction; elevated resting heart rate; prognosis; radiation therapy

Mesh:

Year:  2015        PMID: 25677317     DOI: 10.1016/j.jacc.2014.11.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  34 in total

Review 1.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

Review 2.  Radiation-Induced Cardiovascular Disease.

Authors:  Deepa Raghunathan; Misha Iftikhar Khilji; Saamir A Hassan; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

Review 3.  Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms.

Authors:  Susan G Lakoski; Lee W Jones; Ronald J Krone; Phyllis K Stein; Jessica M Scott
Journal:  Am Heart J       Date:  2015-05-28       Impact factor: 4.749

4.  Role of Interleukin-1 in Radiation-Induced Cardiomyopathy.

Authors:  Eleonora Mezzaroma; Ross B Mikkelsen; Stefano Toldo; Adolfo G Mauro; Khushboo Sharma; Carlo Marchetti; Asim Alam; Benjamin W Van Tassell; David A Gewirtz; Antonio Abbate
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

Review 5.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors:  Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 6.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

Review 7.  Cardiovascular effects of Hodgkin's lymphoma: a review of literature.

Authors:  Aasems Jacob; Bragadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Nasreen Shaikh; David Sharon
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-18       Impact factor: 4.553

8.  Cardiac autonomic dysfunction in survivors of childhood acute lymphoblastic leukemia: The St. Jude Lifetime Cohort Study.

Authors:  Lindsey Christoffersen; Todd M Gibson; Ching-Hon Pui; Vijaya Joshi; Robyn E Partin; Daniel M Green; Jennifer Q Lanctot; Carrie R Howell; Daniel A Mulrooney; Gregory T Armstrong; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  Pediatr Blood Cancer       Date:  2020-05-08       Impact factor: 3.167

Review 9.  Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment.

Authors:  Johan Spetz; Javid Moslehi; Kristopher Sarosiek
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

10.  Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.

Authors:  Wilson Nadruz; Erin West; Morten Sengeløv; Gabriela L Grove; Mário Santos; John D Groarke; Daniel E Forman; Brian Claggett; Hicham Skali; Anju Nohria; Amil M Shah
Journal:  Heart       Date:  2018-05-15       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.